Albendazole and Meropenem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Albendazole (albendazole) and Meropenem (meropenem). Common drug interactions include drug ineffective among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Albendazole and Meropenem. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Albendazole?

Albendazole has active ingredients of albendazole. eHealthMe is studying from 1,394 Albendazole users. Check the latest studies of Albendazole.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

On Jul, 26, 2026

44 people who take Albendazole and Meropenem together, and have interactions are studied.

Albendazole and Meropenem drug interactions.

What are the common drug interactions of Albendazole and Meropenem, by gender? *:

female:

Drug ineffective
General physical health deterioration (weak health status)
Respiratory failure (inadequate gas exchange by the respiratory system)
Strongyloidiasis (infection with strongyloides stercoralis)
Abscess (pus)
Beta haemolytic streptococcal infection (infection with streptococcus pyogenes, a beta-haemolytic bacterium cause mild to moderately severe respiratory tract, skin, and soft tissue)
Cns ventriculitis (inflammation of the ventricles in the brain)
Cytomegalovirus mucocutaneous ulcer (oral ulcers associated with cytomegalovirus infection)
Hydrocephalus (water on the brain)
Sepsis (a severe blood infection that can lead to organ failure and death)

male:

Drug ineffective
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Epistaxis (bleed from the nose)
Headache (pain in head)
Hypotension (abnormally low blood pressure)
Mydriasis (a dilation of the pupil)
Nausea (feeling of having an urge to vomit)
Neurological symptom (symptoms of nervous system disease)
Pain
Respiratory depression (respiration has a rate below 12 breaths)

What are the common drug interactions of Albendazole and Meropenem, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Oxygen saturation decreased
Abdominal pain
Bradycardia (abnormally slow heart action)
Coma (state of unconsciousness lasting more than six hours)
Cough
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Epistaxis (bleed from the nose)
Headache (pain in head)

10-19:

Coagulopathy (blood's ability to clot is impaired)
Hepatic failure (liver failure)
Drug ineffective
Hepatobiliary disease (diseases affect the liver and/or biliary tract)
Chest discomfort
General physical health deterioration (weak health status)
Renal impairment (severely reduced kidney function)
Ventricular fibrillation (abnormally irregular heart rhythm)

20-29:

Drug ineffective
Abscess (pus)
Beta haemolytic streptococcal infection (infection with streptococcus pyogenes, a beta-haemolytic bacterium cause mild to moderately severe respiratory tract, skin, and soft tissue)
Cns ventriculitis (inflammation of the ventricles in the brain)
Cytomegalovirus mucocutaneous ulcer (oral ulcers associated with cytomegalovirus infection)
Hydrocephalus (water on the brain)
Unresponsive to stimuli
Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)

30-39:

Drug ineffective
Septic shock (shock due to blood infection)
Strongyloidiasis (infection with strongyloides stercoralis)

40-49:

Cerebral haemorrhage (bleeding within the brain)
Drug ineffective
Klebsiella infection

50-59:

Clostridium bacteraemia (presence of clostridium bacteria in the blood)
Escherichia infection (bacterial infection by escherichia coli)
Lymphangiectasia intestinal (a disease of the lymphatic vessels of intestine that results in the leakage of protein-rich lymph)
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
Septic shock (shock due to blood infection)
Strongyloidiasis (infection with strongyloides stercoralis)
Drug ineffective
Anaemia (lack of blood)
Bacteraemia (presence of bacteria in the blood)

60+:

Drug ineffective
Strongyloidiasis (infection with strongyloides stercoralis)
General physical health deterioration (weak health status)
Respiratory failure (inadequate gas exchange by the respiratory system)
Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
Klebsiella infection

What are the existing conditions these people have? *

Strongyloidiasis (infection with strongyloides stercoralis): 15 people, 34.09%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 9.09%
Neurocysticercosis (cysts in the functional part of the brain): 4 people, 9.09%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 4 people, 9.09%
Beta Haemolytic Streptococcal Infection (infection with streptococcus pyogenes, a beta-haemolytic bacterium cause mild to moderately severe respiratory tract, skin, and soft tissue): 4 people, 9.09%
Bacteraemia (presence of bacteria in the blood): 4 people, 9.09%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 3 people, 6.82%
Infection: 3 people, 6.82%
Fungal Infection: 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Albendazole and Meropenem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously